Trial Profile
A phase II trial of capecitabine and oxaliplatin (CAPOX) in patients with metastatic breast cancer: Hoosier Oncology Group BRE03-60
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 26 Mar 2008 New trial record.